Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

10x Genomics, Inc. (TXG)

Balance Sheet

Standardized | As Reported Annual | Quarterly
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
   10-K10-K10-K10-KS-1/A
Assets       
Current assets:       
    Cash and cash equivalents  587.4663.6424.265.1 
    Restricted cash  1.016.6   
    Accounts receivable, net  85.351.233.428.1 
    Inventory  60.030.015.38.6 
    Prepaid expenses and other current assets  13.913.08.04.5 
        Total current assets  747.6774.4480.8106.2 
Property and equipment, net  169.572.848.811.1 
Restricted cash  7.68.5   
Operating lease right-of-use assets  60.947.0   
Goodwill  4.5    
Intangible assets, net  25.422.4   
Other noncurrent assets  3.34.323.91.9 
    Total assets  1,018.8929.3605.9124.3 
   
Liabilities and stockholders’ equity       
Current liabilities:       
    Accounts payable  17.44.713.08.8 
    Accrued compensation and related benefits  31.615.412.47.0 
    Accrued expenses and other current liabilities  50.964.624.411.3 
    Deferred revenue  5.34.5   
        Total current liabilities  110.4118.163.032.4 
Operating lease liabilities, noncurrent  76.857.0   
Other noncurrent liabilities  8.23.91.90.8 
    Total liabilities  201.3190.3185.8101.1 
   
Commitments and contingencies (Note 4)       
Stockholders’ equity:       
    Preferred stock     243.2 
    Common stock  0.00.00.00.0 
    Additional paid-in capital  1,680.91,544.2682.511.2 
    Accumulated deficit  -863.3-805.1-262.4-231.1 
    Accumulated other comprehensive loss  0.0-0.10.00.0 
        Total stockholders’ equity  817.6739.1420.1-220.0 
    Total liabilities and stockholders’ equity  1,018.8929.3605.9124.3 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy